BOSCARO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 6.175
EU - Europa 2.836
AS - Asia 632
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AF - Africa 1
Totale 9.656
Nazione #
US - Stati Uniti d'America 6.172
UA - Ucraina 817
IE - Irlanda 397
DE - Germania 363
SE - Svezia 347
DK - Danimarca 316
TR - Turchia 299
IT - Italia 228
FI - Finlandia 174
KR - Corea 165
SG - Singapore 138
GB - Regno Unito 131
BE - Belgio 32
CN - Cina 15
FR - Francia 13
IN - India 8
RU - Federazione Russa 8
EU - Europa 6
AU - Australia 3
CA - Canada 3
JP - Giappone 3
NZ - Nuova Zelanda 3
BG - Bulgaria 2
IR - Iran 2
PL - Polonia 2
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
CH - Svizzera 1
CI - Costa d'Avorio 1
ES - Italia 1
LA - Repubblica Popolare Democratica del Laos 1
NL - Olanda 1
NO - Norvegia 1
RO - Romania 1
Totale 9.656
Città #
Chandler 857
Jacksonville 830
Des Moines 705
Fairfield 423
Dublin 396
Ashburn 347
Boardman 278
Wilmington 251
New York 238
Woodbridge 230
Ann Arbor 179
Seattle 179
Lawrence 168
Princeton 168
Houston 158
Cambridge 145
San Mateo 137
Centro 64
San Diego 55
Brussels 32
Turin 31
Washington 25
Norwalk 23
Civitanova Marche 15
Falls Church 15
Beijing 12
Helsinki 9
Auburn Hills 7
London 6
Redmond 6
Los Angeles 5
Mumbai 5
Ancona 4
Izmir 4
Kilburn 4
Milan 4
Salerno 4
Filottrano 3
Frankfurt am Main 3
New Bedfont 3
Ottawa 3
Porto San Giorgio 3
Pune 3
Rome 3
Siena 3
Edinburgh 2
Fars 2
Hanover 2
Montignoso 2
Moscow 2
Munich 2
Otemae 2
Padova 2
Pescara 2
Phoenix 2
Porto 2
Sofia 2
Stockholm 2
Tappahannock 2
Warsaw 2
Yuncheng 2
Abidjan 1
Acton 1
Adelaide 1
Amsterdam 1
Ascoli Piceno 1
Auckland 1
Borås 1
Brescia 1
Brisbane 1
Chelyabinsk 1
Chengdu 1
Chiswick 1
Christchurch 1
Copenhagen 1
Falkenstein 1
Foresto 1
Gatchina 1
Genova 1
Gillingham 1
Gorizia 1
Greve in Chianti 1
Hollywood 1
Hounslow 1
Kabul 1
Krasnoyarsk 1
Limerick 1
Linköping 1
Madrid 1
Manchester 1
Marseille 1
Miami Beach 1
Mountain View 1
Oslo 1
Plymouth 1
Prescot 1
Reston 1
San Benedetto Del Tronto 1
San Mauro Torinese 1
Senigallia 1
Totale 6.114
Nome #
Prolactinomas,Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas 124
Persistent psychological distress in patients treated for endocrine disease. 119
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. 118
ISOLATION AND CHARACTERIZATION OF MESENCHYMAL CELLS FROM PITUITARY TUMOURS 113
Development of overt Cushing's syndrome in patients with adrenal incidentaloma 108
Protective effect of leg fat against cardiovascular risk factors in obese premenopausal women 97
Age-related changes in glucocorticoid fast feedback inhibition of adrenocorticotropin in man. 95
Multiple endocrine neoplasia type 1 and adrenal lesions 88
Adrenal incidentaloma: surgical update. 88
Production of peroxynitrite by human spermatozoa and its possible role on sperm motility. 87
Psychosocial impairment in patients treated for pituitary disease: a controlled study 86
Development of overt Cushing's syndrome in patients with adrenal incidentaloma. 146 (1): 61-66,2002 86
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. 84
Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas 84
GH secretagogues and hypothalamo-pituitary-adrenal axis 83
Diagnosis and complications of Cushing's syndrome: a consensus statement 82
Aldosterone as a cardiovascular risk factor. 82
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. 82
Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders. 82
Personality characteristics and quality of life in patients treated for Cushing's syndrome 80
Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse. 79
Free thiols in human spermatozoa: involvement of Na/K-ATPase and Ca-ATPase activities in sperm motility. 78
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis. 77
Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. 77
Adipose cell-adrenal interactions: current knowledge and future perspectives. 76
Cushing's syndrome 76
Association of somatotrophinomas with loss of alleles on chromosome 11 and with gps mutations . 76
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. 75
Correlates of perceived health related quality of life in obese, overweight and normal weight older adults: an observational study 74
Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus. 73
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants. 73
Effects of raloxifene on body fat distribution and lipid profile in healthy post menopausal women 72
Diagnosis and management of adrenal incidentalomas. 72
Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. 72
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. 71
Self image and quality of life in acromegaly 71
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. 71
Corticotropin-releasing effect of exarelin, a peptyl GH secretagogue in normal subjects pretreated with metyrapone or RU 486, a glucocorticoid receptor antagonist, and patients with Addison's disease 70
Consideration in diagnosis of Cushing's syndrome 69
Coenzyme Q10 and male infertility 69
Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase. 69
Effect of the serotonin antagonists ritanserin and ketanserin in Cushing disease 68
Molecolar analysis of CDKN1C and TP53 in sporadic adrenal tumors 68
Left ventricular structure and functional characteristic in Cushing's syndrome 67
Sexual symptoms in endocrine diseases: psychosomatic perspectives. 67
Adipose tissue 11 beta-hydrioxysteroid deydrogenase type 1 expression in obesity and Cushing's syndrome 67
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 67
Diagnosis of primary aldosteronism: from screening to subtype differentiation 66
Obesity and body mass index (BMI) in ralation to the life style and psycho-social aspects. 66
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. 66
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 66
Endocrine aspects of cancer gene therapy. 65
Comment - Is there a role for low doses of mitotane (o, p'-DDD) as adjuvant therapy in adrenocortical carcinoma? 65
Recovery of Bone Mineral Density after surgical cure, but not by ketoconazole treatment, in Cushing's syndrome 64
Effect of natural early menopause on bone mineral density. 64
Chemical-physical properties of lipoproteins in anorexia nervosa. 64
Gene therapy for thyroid cancer. 64
Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers 64
In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells. 63
Coenzyme Q10 supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. 63
Obesity and body mass index (BMI) in relation to life-style and psycho-social aspects. 63
Oleoylethanolamide protects human sperm cells from oxidation stress: studies on cases of idiopathic infertility 63
Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease 62
Adrenal incidentaloma: effects on bone metabolism. 62
Expanding role of AMPK in endocrinology 62
Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. 62
Effect of glucocorticoids on adiponectin:a study in healthy subjects and Cushing's syndrome 62
Chemotherapy at the end of life: an open question. 61
Hormonal responses during various phrases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo. 61
Idiopathic infertility: susceptibility of spermatozoa to in vitro capacitation, in the presence and the absence of Palmitylethanolamide (an homologue of Anandamide), is strongly correlated with membrane polarity studied by Laurdan fluorescence. 61
New treatment guidelines on Cushing's disease. 61
Improvement of sperm cells motility after CoQ10 treatment in infertile males with idiopathic asthenozoospermia. 61
ADRENAL MORPHO-FUNCTIONAL ALTERATIONS IN PATIENTS WITH ACROMEGALY. 61
Adrenocortical carcinoma:experience in 45 patients. 61
Bone health and aldosterone excess 60
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 59
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome 59
High cardiovascular risk in patients with Cushing's syndrome accorìging to 1999 WHO/ISH guidelines 59
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation. 59
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. 59
Genetic mutations in thyroid carcinoma 58
Foreword. Glucocorticoid-induced osteoporosis. 58
The diagnosis of Cushing' s syndrome : atypical presentations and laboratory shortcomings 58
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 58
Corticotropin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and Pseudo-Cushing state: a comparative study. 58
Raloxifene and cadiovascular health: its relationschip to lipid and glucose metabolism, hemostatic and inflammation factors and cardiovascular function in postmenopausal women 57
Prevalence and natural history of adrenal incidentalomas. 57
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome 57
Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists 56
Cortical adrenal mitochondrial morphology changes in functional state: new insights. 56
A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma. 55
Risk factors and long-term follw-up of adrenal incidentalomas. 55
Can the ISO9000 quality assessment be applied to the practice of medical oncology? 55
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial 55
Brief report: A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma 54
Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma 54
La nutraceutica nell’infertilità maschile. 54
Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. 54
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome 54
Pharmacologic management of Cushing's syndrome 52
Totale 6.985
Categoria #
all - tutte 40.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.039


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201922 0 0 0 0 0 0 0 0 0 3 4 15
2019/2020943 5 4 170 4 170 14 169 5 177 2 6 217
2020/20212.066 86 265 404 22 236 79 223 93 228 115 231 84
2021/20221.131 50 239 9 64 19 93 39 74 82 135 83 244
2022/20232.866 202 221 173 211 217 897 0 183 594 10 114 44
2023/20241.202 254 40 72 233 229 303 18 49 0 4 0 0
Totale 9.745